Ursula Pertl
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 2
- Oncology 7
- CAR-T cell therapy research 3
- Chemokine receptors and signaling 2
- Co-authors
- Ralph A. Reisfeld (8 shared papers)Holger N. Lode (8 shared papers)Andreas G. Niethammer (5 shared papers)Rong Xiang (4 shared papers)Harald Wodrich (3 shared papers)Brian P. Eliceiri (2 shared papers)Jürgen C. Becker (1 shared paper)Stephen D. Gillies (6 shared papers)
- Journals
- Nature Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)Drugs of today (1 paper)Journal of Clinical Investigation (1 paper)Blood (1 paper)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Ursula Pertl
14 papers receiving 787 citations
Peers
Comparison fields: 5 of 71
- Immunology 363
- Biotechnology 130
- Oncology 260
- Immunology and Allergy 36
- Molecular Biology 347
Countries citing papers authored by Ursula Pertl
This map shows the geographic impact of Ursula Pertl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Pertl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Pertl more than expected).
Fields of papers citing papers by Ursula Pertl
This network shows the impact of papers produced by Ursula Pertl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Pertl. The network helps show where Ursula Pertl may publish in the future.
Co-authors
The 25 scholars most cited alongside Ursula Pertl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 311 | |
| 2 | 2001 | 94 | |
| 3 | 2001 | 80 | |
| 4 | 2000 | 50 | |
| 5 | MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. | 2001 | 50 |
| 6 | Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice. | 2001 | 44 |
| 7 | 1998 | 42 | |
| 8 | 2002 | 36 | |
| 9 | 2002 | 32 | |
| 10 | 2000 | 31 | |
| 11 | 2000 | 31 | |
| 12 | 2000 | 4 | |
| 13 | 1998 | 3 | |
| 14 | MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する | 2001 | 1 |
About Ursula Pertl
Ursula Pertl is a scholar working on Immunology, Oncology, Molecular Biology, Neurology and Genetics, having authored 14 papers that have together received 809 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Neuroblastoma Research and Treatments (4 papers), Virus-based gene therapy research (4 papers), CAR-T cell therapy research (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Chemokine receptors and signaling (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (363 citations), Biotechnology (130 citations), Oncology (260 citations), Immunology and Allergy (36 citations) and Molecular Biology (347 citations). Ursula Pertl has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Ralph A. Reisfeld, Holger N. Lode, Andreas G. Niethammer, Rong Xiang, Harald Wodrich, Brian P. Eliceiri, Jürgen C. Becker, Stephen D. Gillies, Gerhard Gaedicke and J M Ruehlmann. Their work appears in journals such as Nature Medicine, Proceedings of the National Academy of Sciences, Drugs of today, Journal of Clinical Investigation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.